Adhesive patches, preparation

Adhesive patches may also be monolithic or multilayered devices of the reservoir or matrix type for either systemic or local drug delivery (Fig. 8). The two main manufacturing processes to prepare adhesive patches are solvent casting and direct milling (with or without a solvent). The intermediate product is a sheet from which... 

In the preparation of adhesive patches by direct milling on a two-roll mill, the drug and the bioadhesive are homogeneously mixed with or without the aid of a solvent. The polymer/drug mixture may then be compressed to its desired thiekness and patches of appropriate size may be cut or punched out. The polymer/drug mixture prepared with a solvent may require an additional drying step by air or in an oven. 

V.a.1.2. Transdermal preparations. Adhesive patches applied to the skin can be used to deliver oestrogens transdermally, using either a reservoir of liquid or an oestradiol-containing matrix. These systems deliver adequate amounts of oestradiol to maintain plasma levels within the normal range for 24 hours, and some preparations now provide transdermal progestagen also, thus avoiding the need for additional tablets to be taken for part of the cycle. 

Fig. 11. Duration of mucosal adhesion of patches prepared with various viscosity grade HECs (fop) and HPCs (bottom) [86]...

Interest in the adhesion of dosage forms to epithelial surfaces has heen aroused hy the possihility of deliberate contact between oral dosage forms and the gut wall to retard the rate of transit down the gastrointestinal tract, but also by the possibility of dosage forms accidentally adhering to the oesophagus or other epithelial surfaces. Adhesive preparations have been formulated for diverse tasks such as the topical treatment of stomatitis and the administration of insulin. The adhesive nature of transdermal patches is important, as is the adhesion of film coats to tablet surfaces. Adhesion of erythrocytes and bacterial cells to polymer surfaces is also of importance in the understanding, respectively, of blood compatibility of polymers and bacterial infection mediated by catheters. 

Press the adhesive side of the patch to the prepared skin site firmly. Ensure that there is good skin contact, particularly at the edges of the patch. 

The rubber is segregated as big shapeless patches in a continuous nylon phase (the black domains in the micrograph). When the polymerization conditions are not optimum this can also occur in system 3. "Figure 2D" shows a polymer made according to this system where as a result of premature phase separation the polymer has segregated as big particles (about 3 p) and quite a few active groups have not reacted to form nylon blocks. The interfacial adhesion is very small and the mechanical properties of this polymer are equal to those of a polymer prepared according to system 1. 

Occlusion of semi-solid preparations may be useful if systemic absorption is desired. A careful risk-benefit evaluation is then required. Transdermal patches are a more elegant alternative. Being virtually painless and easy to apply, if they achieve controlled delivery, they provide a formulation of choice for prolonged-release systemic uptake. They would have to be adapted to skin maturation, formulated with adhesives with low allergenic potential and be available in different strengths. Of course, the same inter- and intra-patient variability in relation to sites of administration and skin condition occurs in children as in adults. 

Although not strictly used as prime structural adhesives, polymer latices or dispersions have been included here because of their increasing use as aids to bonding in the patch repair of spalled concrete. They usually take the form of a polymer-cement slurry which is applied to the moistened and prepared concrete surface. In general, the repair mortar must then be applied before a film... 

According to the European Pharmacopoeia cutaneous patches are flexible preparations containing 1 or more active substances. They are intended to be applied to the skin. They are designed to maintain the active substance(s) in close contact with the skin such that these may act locally . Cutaneous patches consist of an adhesive basis spread as a uniform layer on an appropriate support made of natural or synthetic material. The adhesive basis is not irritant or sensitising to the skin. The adhesive layer is covered by a suitable protective liner, which is removed before applying the patch to the skin. 

Room Surfoce Location Substrate Type of Patch Test (X-cutor Adhesive Wallboard) Surfoce Preparation Name and Formulation of Encapsulant Obser- vations Pass/ Fall... 

The first priority is preparing the composite for repair and may involve drilling holes for a bolt-on patch or reducing the moisture to a level that will allow heating of the composite and the adhesive for cure. 

In order to validate the adequacy of the surface preparation and the adhesion strength of the carbon fiber—strengthening system, the installer has to perform adhesion tests on the prepared concrete substrate adjacent to repair pipes as directed by the engineer and witnessed by the owner s inspector. The owner s inspector designates the areas for trial adhesion tests prior to the surface-preparation activities. These areas are to be cleaned, prepared, and covered with two-ply CFRP system test patches with minimum dimensions of 2 x 2 ft (60 x 60 cm). The patch consists of two orthogonal layers of CFRP. 

---